LB Pharmaceuticals LBRX Business Model Review LB Pharmaceuticals Beats EPS Estimates With Narrower Loss Exicure XCUR Stock Next Week Touches Low 20260420 NAVI Navient Corporation posts sharp Q4 2025 earnings and revenue misses but stock moves modestly higher Is Fractyl Health GUTS stock breaking out 479 20260420 What VALE SA VALE accounting reveals about the business VALE SA Misses Estimates by 17 Why New Era NUAI is still under the radar Volatility Increases 20260508 How Pimco PML translates market opportunities into growth 013 20260508 The inflation impact visible in Intellia Therapeutics NTLA results Q4 2025 EPS Tops Views How sustainable is FingerMotion FNGR profit margins 287 20260503 DBA SBSW Q2 2022 Results Fall Short EPS 423 Revenue NA Fulgent Genetics FLGT Stock Slides 303 Support at 1491 20260517 Goldman Sachs Adjusts Crypto ETF Holdings Shifts Focus to Hyperliquid Stantec STN Stock Consolidating at 7729 Next Move Ahead 20260518 Oil Shipping Disruption Worsens as Iran Tightens Grip on Strait of Hormuz DoubleLine DSL Stock Today Rallies 173 Resistance at 1143 20260520 Vestand VSTD Q1 2025 Results No Fireworks But Solid Execution BioVie BIVIW Stock Steady at 031 Support at 029 20260520 VSEC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat YTRA Q1 2026 Earnings Narrower Loss than Expected Shares Rally 6 WYFI Q1 2026 Earnings EPS Misses Estimates Stock Climbs 4 JOE Q1 2026 Earnings EPS of 024 Reported Stock Sees Slight Decline SMCI Q1 2026 Earnings Strong EPS Beat Drives Stock Rally CDP COPT Defense posts 14 YoY Q4 2025 revenue gain narrow EPS miss stock dips slightly BSAC Q1 2026 Earnings EPS Surpasses Estimates but Stock Ticks Lower